Senores Pharmaceuticals announces a joint venture, Amerisyn LLC, to target U.S. federal, veteran, and military supply contracts.
The JV leverages Senores' manufacturing and R&D to supply pharmaceutical products to U.S. government agencies.
The company's portfolio includes 46 ANDAs and 137 strengths, with a pipeline of 22 ANDAs and 52 strengths.